HomeESLA • NASDAQ
add
Estrella Immunopharma Inc
Previous close
$2.29
Day range
$2.28 - $2.69
Year range
$0.70 - $3.15
Market cap
92.30M USD
Avg Volume
371.96K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.54M | 40.37% |
Net income | -5.54M | -40.34% |
Net profit margin | — | — |
Earnings per share | -0.15 | — |
EBITDA | — | — |
Effective tax rate | -0.02% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.32M | -85.45% |
Total assets | 2.98M | -68.45% |
Total liabilities | 9.08M | 2,176.01% |
Total equity | -6.09M | — |
Shares outstanding | 37.07M | — |
Price to book | -14.31 | — |
Return on assets | -510.99% | — |
Return on capital | 350.37% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -5.54M | -40.34% |
Cash from operations | -414.88K | -42.32% |
Cash from investing | — | — |
Cash from financing | 1.31M | 584.56% |
Net change in cash | 895.12K | 259.31% |
Free cash flow | 1.86M | 115.00% |
About
Founded
2006
Headquarters
Website
